Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

171 Results
Title Activity Code Posting Date Sort ascending Expiration Date
Notice of Special Interest (NOSI)— HIV Drug Resistance Assays and Actionable Data Dissemination Strategies- NOT-AI-21-056 Multiple June 17, 2021 May 08, 2024
Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)- RFA-AI-20-069 R61/R33 June 15, 2021 October 14, 2021
Limited Competition—Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)- PAS-21-245 R34 June 14, 2021 September 08, 2024
Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed)- RFA-AI-21-046 R01 June 10, 2021 October 23, 2021
Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed)- PAR-21-257 S10 June 03, 2021 May 25, 2022
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-21-155 R15 May 19, 2021 May 08, 2024
Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed)- RFA-AI-21-016 U01 May 11, 2021 September 04, 2021
Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed)- RFA-AI-21-039 UM1 May 07, 2021 August 05, 2021
Systems Approach To Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)- RFA-AI-21-017 R01 April 27, 2021 September 09, 2021
Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)- RFA-AI-21-030 U54 April 20, 2021 October 14, 2021
NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed)- PAR-21-209 R21 April 19, 2021 July 28, 2021
Emergency Award—RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)- RFA-OD-21-009 U01 April 13, 2021 July 08, 2021
Emergency Awards—Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)- RFA-OD-21-008 U01 April 13, 2021 July 08, 2021
Understanding HIV Reservoir Dynamics (P01, Clinical Trial Not Allowed)- RFA-AI-21-013 P01 April 07, 2021 July 31, 2021
Limited Interaction Targeted Epidemiology (LITE-2)—To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional)- RFA-AI-21-018 UG3/UH3 April 07, 2021 August 05, 2021
Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed)- RFA-AI-21-019 U01 April 02, 2021 August 25, 2021
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases—Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed)- RFA-AR-21-016 UC2 March 31, 2021 July 16, 2021
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases—Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional)- RFA-AR-21-015 UC2 March 31, 2021 July 16, 2021
Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed)- RFA-AI-21-012 R61/R33 March 31, 2021 August 05, 2021
Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional)- RFA-AI-21-025 R01 March 30, 2021 July 31, 2021
Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional)- RFA-AI-21-024 R01 March 30, 2021 August 05, 2021
Respond—Epidemiology to End the HIV Epidemic (RESPOND—EEE) (R01 Clinical Trial Optional)- RFA-AI-21-023 R01 March 30, 2021 July 31, 2021
Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)- RFA-AI-21-009 U01 March 30, 2021 July 31, 2021
Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)- RFA-MD-21-004 R01 March 23, 2021 August 25, 2021
Notice of Special Interest (NOSI)— Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies- NOT-AI-21-032 R01, R21, R03 March 23, 2021 May 08, 2024